What are the odds of catching a meaningful infection from sharing a drink bottle or cup?
Evidence quality 4.5/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 3/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 4/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 5/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, activity-specific
1 in 10,000
0.01% lifetime chance
Most people overestimate this.
range — to 1 in 1,000
≈ As likely as
Perceived
The instinct that sharing a bottle is a disease vector runs deep — reinforced by the knowledge that saliva contains bacteria and viruses, that backwash is visibly real, and that oral herpes, mononucleosis, and meningitis are all popularly associated with saliva contact. The common framing is: the first person to drink from the bottle leaves pathogens behind, and the second person who pours from it or drinks after carries those pathogens away. Meningitis among university students is particularly salient in this mental model, as is the recurring advice to "not share drinks" from school health campaigns. Actual estimates of per-event transmission probability are not widely available to the public, so this is flagged as intuition.
Source: editorial intuition, not polled
Actual
~0.4% of university students carry Neisseria meningitidis in their saliva (vs. 32% nasopharyngeal carriage)
UK university students (Orr et al. 2003, Emerging Infectious Diseases, n=258)
Show derivation
No study has directly quantified per-event transmission probability for any meaningful infection via shared cup or bottle. The two strongest anchors are: (1) Orr et al. 2003 (Emerging Infectious Diseases / CDC), which tested saliva carriage of meningococcus — the pathogen most commonly cited in "don't share drinks" campaigns — and found carriage in only 0.4% of students' saliva swabs vs. 32% in nasopharyngeal swabs, and which also reviewed a case-control study among university students that "found no association between meningococcal acquisition and sharing of glasses or cigarettes"; (2) Manangan et al. 1998 (CDC, AJIC), which reviewed decades of surveillance around the common communion cup scenario (hundreds of thousands of people sharing a cup weekly for years) and concluded "no documented transmission of any infectious disease has ever been traced to the use of a common communion cup" and that "the risk is so small that it is undetectable." The 0.0001 lifetime estimate is a derived upper bound consistent with zero detected transmissions across millions of observed cup-sharing events. For the other candidate pathogens: HSV-1 is already present in ~63.5% of US adults (iScience 2024 meta-analysis), making most participants in any sharing event immune; for the ~36% who are seronegative, cup sharing is far less efficient than direct mucosal contact for primary transmission. EBV/mononucleosis is already present in ~95% of adults globally (StatPearls) and is documented to transmit primarily via kissing or sexual contact at university age; household secondary attack rates are low. Strep throat transmission controlled human infection studies found no evidence of fomite transmission (PMC 2024). The 1 in 10,000 lifetime figure represents the upper bound on meaningful clinical infection (hospitalisation, lasting pathogen acquisition) specifically attributable to drink-sharing as a route, as distinct from other household contact routes that would occur anyway.
Caveats: This entry addresses the risk of a meaningful infection — one involving a pathog…
This entry addresses the risk of a meaningful infection — one involving a pathogen with lasting clinical consequences — from sharing a drink bottle or cup where one person's saliva enters the liquid. The risk of a self-limiting cold or mild flu from sharing a bottle with someone who is actively symptomatic is not measured here and is not meaningfully separated from the general household droplet and contact-transmission risk that exists regardless of whether you shared a bottle. All the pathogens most commonly named in this concern (meningococcus, HSV-1, EBV, strep) have low or no documented transmission probability via this route for distinct mechanistic reasons: meningococcus almost never reaches saliva in detectable concentrations (0.4% saliva carriage); HSV-1 is already carried by 63.5% of US adults; EBV is already carried by ~95% of global adults and transmits mainly via intimate contact; strep is transmitted primarily via respiratory droplets, not fomites. The CDC communion cup analysis, which represents decades of surveillance across millions of cup-sharing events, found the risk "so small it is undetectable." None of this means backwash is aesthetically neutral; it means the infection biology does not match the cultural fear. The caveat that does apply: sharing a bottle with someone who is visibly symptomatic (actively coughing, with an obvious cold sore, or known to have strep throat) raises even the already-low per-event risk meaningfully — the "don't share drinks when sick" advice is rational and is not what this entry challenges.
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
What are the odds of getting a fatal fox tapeworm infection from eating wild berries?
What are the odds of getting a fatal fox tapeworm infection from eating wild berries?
Chiropractic neck manipulation
What are the odds of stroke or serious injury from chiropractic neck manipulation?
Hepatitis A (travel)
What are the odds of contracting hepatitis A as an unvaccinated traveler to an endemic region?
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
The image that makes “don’t share drinks” feel urgent is the wrong one. The fear is usually of meningitis, herpes, or mono — dramatic infections with meningococcus, HSV-1, or EBV as the named villain. Orr and colleagues (2003, CDC’s Emerging Infectious Diseases) tested this directly: they swabbed the saliva of 258 UK university students — the exact demographic and pathogen combination most invoked in the fear — and found meningococcal carriage in exactly one student’s saliva (0.4%), compared to 32% in nasopharyngeal swabs. The same paper reviewed a case-control study of university students that found no association between sharing glasses or cigarettes and meningococcal acquisition. Their conclusion was that drink-sharing should not even qualify as an indication for chemoprophylaxis after a case exposure — a public-health-facing rebuttal of the premise. A CDC-authored review of the communion cup scenario, which involves hundreds of thousands of people sharing a common cup weekly for years, concluded that no documented transmission of any infectious disease has ever been traced to a common communion cup and that the risk is “so small that it is undetectable.”
The background immunity picture further constrains the risk. About 63.5% of US adults already carry HSV-1 (iScience 2024 meta-analysis of national seroprevalence data), meaning most sharing partners are already immune to primary oral herpes acquisition. For EBV, roughly 95% of global adults are already infected — StatPearls notes it “is not considered a highly contagious disease” even while acknowledging saliva as a transmission route; the primary documented acquisition route among seronegative young adults in the Crawford cohort study (46% seroconversion over three university years) was penetrative sexual intercourse, not cup-sharing. Strep throat, the most mundane of the candidate pathogens, appears to transmit primarily via respiratory droplets: a 2024 controlled human infection trial found no evidence of fomite transmission in a deliberately designed study.
Where the fear is calibrated: none of this applies to sharing a bottle with someone who is visibly and actively ill. A person with an open cold sore shedding HSV-1, or with documented strep throat, or during the acute febrile phase of a cold or flu, presents a meaningfully higher transmission risk than an asymptomatic carrier — and the “don’t share drinks with sick people” rule is rational. The finding here is that the ambient, background-level risk from sharing a bottle with a random person who is not acutely symptomatic is so small that decades of public-health surveillance have not been able to detect it. The backwash is real; the infection risk from it, in the general case, is not.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] Emerging Infectious Diseases (CDC journal) — Orr HJ, Gray SJ, Macdonald M, Stuart JM — Saliva and Meningococcal Transmission
Saliva and Meningococcal Transmission- Statistic
Meningococcal saliva carriage: 0.4% (1 of 258 students) vs. nasopharyngeal carriage 32.2%; case-control study among university students found no association between meningococcal acquisition and sharing of glasses or cigarettes- Excerpt
“"Low prevalence of carriage in saliva swabs (one swab [0.4%]) suggests that low levels of salivary contact are unlikely to transmit meningococci. On the basis of this evidence, we propose that guidelines for public health management of meningococcal disease should not include low-level salivary contact (e.g., sharing drinks) with a case-patient as an indication for chemoprophylaxis." ”
- Source data from
- 2003-10-01
- Accessed
- 2026-05-03 · archived copy
- Calculation
- Orr et al. is the direct empirical test of saliva as a meningococcal transmission route — the specific pathogen most feared in the "don't share drinks" narrative. The result is striking: despite 32% nasopharyngeal carriage, only 0.4% of saliva swabs were positive, meaning the organism almost never reaches the saliva in sufficient quantity to transmit. The case-control data (no association with drink-sharing and disease acquisition) adds epidemiological confirmation on top of the biological finding. The authors explicitly recommend removing drink-sharing from the chemoprophylaxis eligibility criteria — a public-health-facing conclusion that directly addresses the fear motivating this entry. Used as the primary evidence anchor for the meningococcal component of the native stat.
- Independence
- Independent UK epidemiological study published in CDC's own journal; distinct from the AJIC communion cup review below and the HSV-1 and EBV sources.
-
[2] American Journal of Infection Control (Manangan LP, Sehulster LM, Chiarello L, Simonds DN, Jarvis WR — CDC Hospital Infections Program) — Risk of infectious disease transmission from a common communion cup
Risk of infectious disease transmission from a common communion cup- Statistic
No documented transmission of any infectious disease traced to use of a common communion cup; CDC conclusion: risk 'so small that it is undetectable'- Excerpt
“"Although no documented transmission of any infectious disease has ever been traced to the use of a common communion cup, a theoretical risk of transmitting infectious diseases exists. The consensus of the CDC is that such risk is so small that it is undetectable." ”
- Source data from
- 1998-10-01
- Accessed
- 2026-05-03 · archived copy
- Calculation
- The communion cup scenario is the highest-frequency shared-cup event in the epidemiological literature: hundreds of thousands of participants, weekly exposure across decades, a large unselected population. Despite this scale of observation, the CDC-authored AJIC review identified zero documented disease transmissions. If we conservatively assume 100 million person-cup-sharing events observed and zero infections detected, the per-event upper bound on meaningful infection probability is on the order of 1 in 10 million. The lifetime 0.0001 estimate allows for substantially more risk than this (treating it as a conservative upper bound), since the communion cup scenario may involve less backwash saliva exchange than a shared personal bottle. Used as the primary anchor for the "undetectable signal" framing.
- Independence
- Independent CDC epidemiological review, distinct from the Orr meningococcal study above and the virology sources below.
-
[3] iScience (Cell Press) — Epidemiology of herpes simplex virus type 1 in the United States: Systematic review, meta-analyses, and meta-regressions
Epidemiology of herpes simplex virus type 1 in the United States: Systematic review, meta-analyses, and meta-regressions- Statistic
Pooled mean HSV-1 seroprevalence among US adults: 63.5% (95% CI 61.3–65.7%); seroprevalence declining ~1% per year; ~36% of US adults are seronegative and theoretically susceptible to primary HSV-1- Excerpt
“"The pooled mean HSV-1 seroprevalence was 63.5% (95% CI: 61.3–65.7) among general-population adults... Seroprevalence declined by 0.99-fold (95% CI: 0.99–0.99) per year." ”
- Source data from
- 2024-08-05
- Accessed
- 2026-05-03 · archived copy
- Calculation
- The 63.5% US adult seroprevalence figure establishes that the majority of participants in any drink-sharing event already carry HSV-1 and are immune to primary acquisition. For the ~36% who are seronegative, HSV-1 can in principle be acquired via contact with infected saliva; however, transmission efficiency via fomite (a shared bottle) is substantially lower than via direct mucosal contact, and no study has quantified per-event cup-sharing transmission probability. The high background immunity means the expected proportion of sharing partners who are both (a) HSV-1 positive and (b) actively shedding virus in detectable quantities and (c) sharing a bottle with a seronegative partner is low. Used to establish the HSV-1 context and immunity floor.
- Independence
- Independent of the meningococcal CDC sources; distinct pathogen, distinct methodology (meta-analysis of seroprevalence studies).
-
[4] StatPearls Publishing / NCBI Bookshelf — Epstein-Barr Virus — StatPearls
Epstein-Barr Virus — StatPearls- Statistic
Global adult EBV seroprevalence: ~95%; US ages 18–19: 82.9% already infected; EBV 'is not considered a highly contagious disease'; kissing is the major route of primary EBV transmission among adolescents and young adults- Excerpt
“"Nearly 95% of the world's adult population has EBV exposure... The transmission of the Epstein Barr virus occurs in several ways, such as deep kissing or food-sharing... EBV is not considered a highly contagious disease." ”
- Source data from
- 2023-01-01
- Accessed
- 2026-05-03 · archived copy
- Calculation
- The ~95% global adult seroprevalence makes EBV acquisition via drink-sharing negligible for the vast majority of adults — only the ~5% globally (higher among younger US adults) who are seronegative are at any risk of primary EBV infection. Even for this seronegative minority, kissing is the documented primary transmission route (Crawford et al. 2006, CID: 46% seroconversion over 3 university years, with penetrative sexual intercourse the primary identified risk factor), not cup-sharing. StatPearls explicitly classifies EBV as "not highly contagious." Used to establish that mononucleosis from shared drinks is an extremely unlikely scenario given background immunity and preferential transmission routes.
- Independence
- Independent reference source (NIH/NCBI StatPearls), distinct from the meningococcal CDC studies and the HSV-1 meta-analysis.